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ABSTRACT
Differences in Upper Body Posture and Postural Muscle Activation in Females with
Larger Breast Sizes
Breast hypertrophy is a common medical condition whose morbidity has
increased over recent decades. Symptoms of breast hypertrophy often include
musculoskeletal pain in the neck, back and shoulders, and numerous psychosocial health
burdens.
To date, reduction mammaplasty (RM) is the only treatment shown to
significantly reduce the severity of the symptoms associated with breast hypertrophy.
However, due to a lack of scientific evidence in the medical literature justifying the
medical necessity of RM, insurance companies often deny requests for coverage of this
procedure. Therefore, the purpose of this study is to investigate biomechanical
differences in the upper body of women with larger breast sizes in order to provide
scientific evidence of the musculoskeletal burdens of breast hypertrophy to the medical
community
Twenty-two female subjects (average age 25.90, ± 5.47 years) who had never
undergone or been approved for breast augmentation surgery, were recruited to
participate in this study. Kinematic data of the head, thorax, pelvis and scapula was
collected during static trials and during each of four different tasks of daily living.
Surface electromyography (sEMG) data from the Midcervical (C-4) Paraspinal, Upper
Trapezius, Lower Trapezius, Serratus Anterior, and Erector Spinae muscles were
recorded in the same activities. Maximum voluntary contractions (MVC) were used to
normalize the sEMG data, and %MVC during each task in the protocol was analyzed.
Kinematic data from the tasks of daily living were normalized to average static posture
data for each subject. Subjects were divided into groups of normal control subjects
(n=12, reported bra-cup size A, B, or C) or hypertrophy subjects (n=10, reported bra-cup
size D or larger). To compare results between the groups, a two-tailed independent t-test
was performed for each dependent variable with significance set at α=0.05.
Significant differences in torso flexion were found between the normal control
group and the hypertrophy group during both the pencil activity (p=0.054) and the step
up activity (p=0.001). There were also significant differences in lower trapezius muscle
activation during the static trial (p=0.051). Although not significant, women in the
hypertrophy group also tended to exhibit greater head flexion, pelvic tilt and torso flexion
under static conditions, and also exhibited increased muscle activation in all five muscles
under the same conditions.
Results of this study provide scientific information regarding the effects of breast
hypertrophy on the musculoskeletal system. While none of the postural alterations seen
in women with large breasts were significantly different from those seen in women with
smaller breasts, the data presented shows a trend towards altered musculoskeletal
alignment due to the size and weight of larger breasts that should be considered when
determining the medical necessity of reduction mammaplasty.
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INTRODUCTION
Breast hypertrophy is a common medical condition whose morbidity has
increased over recent decades.

While the exact definition of breast hypertrophy is

unclear, it is characterized by an increase in the volume and weight of breast tissue
beyond normal proportions [1]. The exact etiology of breast hypertrophy is unknown,
especially when it occurs during puberty and early adolescence.
Common symptoms associated with breast hypertrophy include pain in the neck,
back and shoulders, intertrigo, shoulder grooving from bra straps, headaches, rash, and
breast pain [2-9]. Women with breast hypertrophy may also report neurologic symptoms
of the upper extremity such as ulnar nerve neuropathies, hand numbness, and carpal
tunnel syndrome [1, 4, 8-14].
Psychosocial burdens are also associated with breast hypertrophy. Many women
with breast hypertrophy report feelings of embarrassment, difficulty finding properly
fitting clothing, low self-esteem, and difficulty participating in sports [12, 13, 15, 16]. As
a result, women with hypertrophic breasts are often dissatisfied with their self-image and
may seek reduction mammaplasty as a way to reduce both pain and psychosocial distress.
To date, there is no lasting non-operative treatment for breast hypertrophy [1]. As
a result, women with severe breast hypertrophy are most often treated by reduction
mammaplasty. Bilateral reduction mammaplasty is a surgical technique in which excess
breast tissue is removed from both breasts.

Objectives of reduction mammaplasty

include: lifting of the nipple and areola, reduction of the breast skin envelope, overall
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improvement in the shape of the breast, and preservation of lactation and breast
sensitivity [17, 18]. Reduction mammaplasty is the only treatment proven to effectively
reduce the severity of the symptoms associated with breast hypertrophy.
Over the past few years reduction mammaplasty has become one of the most
common reconstructive surgical procedures performed by plastic surgeons in the United
States.

The number of reduction mammaplasty surgeries performed each year has

increased 25% since 2000. In 2007, 106,179 breast reductions were performed, making
reduction mammaplasty the number five reconstructive procedure in 2007 [19].
Recent research has examined the correlation between the relief of the symptoms
of breast hypertrophy and surgery. Most recently, a study entitled “Breast Reduction:
Assessment of Value and Outcomes” (BRAVO) was performed using validated selfreport questionnaires to evaluate the burden of breast hypertrophy. This multicenter
study comparatively assessed both women presenting for breast reduction and a control
group of large-breasted women. This study found that women presenting for surgery
experienced more breast-related symptoms (especially pain) relative to the control group,
were unable to obtain long-term relief of symptoms form conservative treatments, and
reported substantial pain relief following breast reduction surgery, essentially allowing
them to return to normal functioning. Based on the results of this study, Kerrigan et al
were able to define the medical necessity of breast reduction surgery, and determined that
women reporting two or more of the key physical symptoms all or most of the time had
the most substantial health burden and were most likely to benefit from surgery [1, 20].
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Despite increasing recognition of breast hypertrophy as a morbid disease, the
debate over whether reduction mammaplasty should be considered a cosmetic or
reconstructive procedure continues. While many prospective studies have been published
indicating the positive health related outcomes of reduction mammaplasty, no studies to
date have provided solid objective measurements as evidence of variables that indicate
when reduction mammaplasty becomes medically necessary.

As a result, insurance

companies often reject patients who do not meet their arbitrary requirements for
determining medical necessity despite having obvious symptoms.
Problem Statement
The purpose of this study is to investigate biomechanical differences in the upper
body of women with larger breast sizes in order to provide scientific evidence of the
musculoskeletal burdens of breast hypertrophy to the medical community.

For the

purposes of this study, subjects were divided into groups of normal control subjects
(reported bra-cup size A, B, or C) or hypertrophy subjects (reported bra-cup size D or
larger) [21]. The evaluation of each subject has three primary objectives:
Objective 1
Quantify the kinematics of the head, thorax, pelvis and scapula during different
tasks of daily living in comparison to the same kinematics during a static standing trial.
The kinematic variables of interest will be: Head flexion and extension, thoracic flexion
and extension, pelvic tilt, scapular protraction and retraction, scapular upward rotation,
and lateral torso flexion.
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Objective 2
Quantify the maximum amplitude (%MVC) of muscle activation of each of the
muscles of interest during each task of daily living in comparison to the maximum
amplitude (%MVC) of muscle activation of each muscle during a static standing trial.

Objective 3
Quantify the health burden of breast hypertrophy based on the breast symptom
summary score (BSS), calculated from the Breast Related Symptoms Questionnaire
(BRSQ).
Research Hypothesis
Based on these three objectives, the research hypothesis for this study is that the
BSS scores, upper body biomechanics, and cervico-thoracic muscle activation will differ
between the two groups due to the size and weight of their breasts. Based on the research
hypothesis for this study, the statistical hypotheses in terms of the null hypothesis (Ho)
and alternative hypothesis (Ha) for this study are:


Ho = 1   2 (Normal control subjects and Hypertrophy subjects will exhibit the
same)
o BSS scores
o Muscle Activation
o Head Flexion and Extension
o Torso Flexion and Extension
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o Pelvic Tilt
o Scapular Protraction and Retraction
o Scapular Rotation
o Lateral Torso Flexion


Ha = 1   2 (Normal control subjects and Hypertrophy subjects will exhibit
different)
o BSS scores
o Muscle Activation
o Head Flexion and Extension
o Torso Flexion and Extension
o Pelvic Tilt
o Scapular Protraction and Retraction
o Scapular Rotation
o Lateral Torso Flexion

Assumptions


It is assumed that subjects performed each task as they would if no one was
watching them so that movement can be accurately assessed and normalized
across tasks.



All subjects were required to wear a regular (non sports) bra during testing. It is
assumed that the support given by the bra (i.e. location of bra straps, presence of
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underwire) is uniform across all subjects and has minimal, if any, effect on the
biomechanics of the musculoskeletal system.

Limitations
The results of this study will be limited by the group of women represented in the
sample population: women over the age of 18 who have never undergone or been
approved for breast augmentation surgery.

Delimitations
This study will be applicable to all females who have never undergone breast
augmentation surgery.

Operational Definitions
This study will examine 8 distinct dependent variables, each of which presents a
specific method of measurement.


Breast Related Symptoms Scores (BSS): Computed by averaging the item scores
from the Breast Related Symptoms Questionnaire and linearly transforming the
average to a 0-to-100 scale.



Muscle Activation: Reported as a percentage of maximum muscle contraction for
each muscle of interest
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Head Flexion: Quantified using a 6-camera optical motion camera system and
reported in units of degrees.

Values were normalized as an average of the

maximum change from static measurements, with positive values representing
head flexion.


Torso Flexion and Extension: Quantified using a 6-camera optical motion camera
system and reported in units of degrees. Values were normalized as an average of
the maximum change from static measurements, with positive values representing
torso flexion.



Pelvic Tilt:

Quantified using a 6-camera optical motion camera system and

reported in units of degrees.

Values were normalized as an average of the

maximum change from static measurements, with positive values representing
anterior tilt.


Scapular Protraction: Quantified using a 6-camera optical motion camera system
and reported in units of degrees. Values were normalized as an average of the
maximum change from static measurements, with positive values representing
shoulder protraction.



Scapular Upward Rotation: Quantified using a 6-camera optical motion camera
system and reported in units of degrees. Values were normalized as an average of
the maximum change from static measurements, with positive values representing
upward rotation.
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Lateral Torso Flexion:

Quantified using a 6-camera optical motion camera

system and reported in units of degrees. Values were normalized as an average of
the maximum change from static measurements, with positive values representing
flexion towards the left side of the body.
BSS scores will only be computed at the beginning of the data collection since that is
the only time they will be measured.

The remaining dependent variables will be

measured during both static trials and during each task of daily living trial with the
exception of scapular upward rotation and lateral torso flexion, which will only be
measured during lift and static trials.
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REVIEW OF LITERATURE
Breast hypertrophy has been widely associated with both physical and
psychosocial symptoms. Many qualitative studies have provided insight on the lessening
of severity of these symptoms following reduction mammaplasty, yet few studies have
aimed to explain the mechanism of the musculoskeletal pain seen among women with
larger breasts.
While several surgical procedures have been presented to achieve reduction in
breast size, the degree of relief of breast hypertrophy symptoms does not appear to be
related to the surgical procedure chosen. Therefore, for the purposes of this study, the
different types of surgical procedures will not be outlined and this review will focus
solely on breast hypertrophy and its effects on the spinal column, the health-related
quality of life of women with breast hypertrophy, alternative methods of treatment, and
determination of coverage by third party payers.
Breast Hypertrophy and the Spinal Column
Deviated posture of the head, neck and shoulders has long been recognized as a
potential contributing factor of the onset of upper body musculoskeletal pain. Posture is
maintained by ligamentous and muscular support as a result of the body’s effort to remain
erect [8]. Research suggests that breast hypertrophy causes postural alterations related to
the skeletal system, specifically the spinal column.
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In general, the spinal column is a fairly flexible unit which can change shape on a
limited basis in order to adjust to the location of the body’s center of gravity [8]. In
individuals without significant postural deviations, the center of gravity of the human
body profile passes from the external auditory meatus, through the odontoid process,
slightly posterior to the center of the hip joint, slightly anterior to the center of the knee,
and to a point slightly anterior to the lateral malleoli [8, 22]. However, in women with
breast hypertrophy, the nipple descends to a lower position than the ideal [1], leading to
secondary effects related to the location of the center of gravity. This change in location
of the center of gravity causes increased curvature of the cervical spine (increased
cervical lordosis or head flexion) and increases the tension in the cervical extensor
muscles [5, 8].
The increased curvature of the cervical spine commonly seen in women with
hypertrophic breasts may also place the head and shoulders forward, causing further
postural alterations. Forward head position is defined as excessively anterior position of
the head in relation to a theoretical plumb line perpendicular to the body’s center of
gravity [23]. It has been postulated that forward head position of the head may result in a
sustained isometric contracture of the neck muscles [8, 24]. As mentioned before, pain in
the head, neck and shoulders are common symptoms seen in women with breast
hypertrophy [2-9]. These common symptoms may be explained as a result of the fatigue
experienced by the muscles in the neck while trying to maintain this faulty forward head
position [8, 23].
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Forward head position has also been associated with an increase in thoracic
kyphosis angle and may also lead to a downward rotation of the scapula and acromion,
placing the shoulders in a deviated forward position [8, 24, 25]. This altered scapula
position may decrease the range of motion of the upper extremity and change the
biomechanics of the shoulder joint, resulting in musculoskeletal pain over time.
In women with breast hypertrophy, the altered position of the scapula due to the
weight of the breasts may lead to swelling and stiffness of the rotator cuff and can induce
painful, limited motion of the shoulder girdle [8, 24]. Thus, women who suffer from
breast hypertrophy may suffer from functional disabilities in the upper body, and may be
limited in their ability to perform tasks of daily living due to decreased range of motion
of the shoulder girdle.
Changes in skeletal alignment may promote muscular changes that create
excessive or abnormal muscle tension. Posturally induced muscle weakness has been
defined as the effect on muscles of remaining in a lengthened condition, however slight,
beyond the neutral (physiological rest) position [26]. Therefore, if a muscle becomes
positionally elongated, it is likely that this muscle will become relatively weak over time.
Similarly, a muscle that becomes positionally shortened will become relatively stronger
over time.
Changes in the direction of muscle pull as a result of an altered scapula position
may affect the amount of muscle tension required to maintain a static position [23], thus
inducing fatigue and weakness in the scapula musculature similar to that seen in patients
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who present with shoulder impingement syndrome.

Kisner and Colby suggest that

increased scapular abduction or a “forward shoulders” posture may be partly caused by
weakness of the scapular retractors, such as the upper trapezius, lower trapezius, and
rhomboid muscles [26]. Similarly, Zimmerman et al propose that heavy breasts lead to
gradual and continuous tension on the middle and lower trapezius muscle fibers
consequently contributing to the shoulder pain in women with breast hypertrophy present
[8].
Along with musculoskeletal pain, women with breast hypertrophy may present
with neurological complications. It has also been suggested by several authors that the
altered position of the scapula results in compression of the brachial plexus, thus leading
to neurologic complications of the upper extremity [10, 27]. Neurologic complications
often include ulnar nerve paresthesis, hand numbness and carpal tunnel syndrome [4, 814]. It is speculated that the brachial plexus compression between the coracoid process
of the scapula and the rib cage occurs as forward depression of the shoulders tilts the
coracoid downward in women with breast hypertrophy [10].
In a study by Kaye et al, it was found that almost all women tested presented with
characteristic area of ulnar hypesthesia in each hand regardless of complaints of pain or
numbness in their hands [27]. While ulnar hypesthesia should not be disregarded as a
symptom seen in women with breast hypertrophy, it is important to note that this study
gives very little information about the methods used to gather data, and should therefore
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not be treated as true scientific evidence of its association with the symptoms of breast
hypertrophy.
Health-Related Quality of Life
Breast hypertrophy has been shown to create significant social and psychological
problems for the women who suffer from this condition. Major psychosocial complaints
of women presenting with breast hypertrophy include: unwanted attention, poor selfesteem, difficulty finding proper fitting clothing, difficulty and embarrassment during
exercise, negative impact on intimate relationships, and avoidance of social occasions [2,
4, 15, 28].
A myriad of physician-based questionnaires have been used in an attempt to
evaluate the health-related quality of life of women with hypertrophic breasts. One of the
most well documented tools for evaluating physical and mental health-related quality of
life is Short Form 36 [2, 14, 21, 28, 29]. Short Form 36 (SF-36) includes eight domains:
physical function and activities, daily activities, emotional status, social activities, mental
health, vitality and energy, pain, and general health perceptions. For each domain, higher
scores indicate better health status and higher quality of life [21].
Several studies on outcomes of reduction mammaplasty have shown that women
with symptoms of breast hypertrophy score significantly lower preoperatively on SF-36
than women representing the normal population [2, 7, 13, 14, 17, 21, 28-30]. These
findings indicate that women who suffer from breast hypertrophy have a lower perceived
health-related quality of life than the normal female population. These same studies also
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found that despite low preoperative scores on SF-36, reduction mammaplasty resulted in
improved postoperative (3 to 12 months) scores on SF-36 [2, 14, 21, 28, 30]. Most
notably, a prospective questionnaire study conducted by Blomqvist et al in 2000
evaluated

reduction

mammaplasty

patients

SF-36

scores

preoperatively

and

postoperatively (6 and 12 months) in comparison to an age-matched group of Swedish
women.

In this study, patients who underwent reduction mammaplasty scored

significantly higher on SF-36 6 and 12 months postoperatively and were similar to the
SF-36 scores for the age-matched group [2].

These results not only indicate

improvement, but normalization.
More recently, Kerrigan et al developed a new self-report questionnaire in order
to systematically quantify breast-specific symptoms.

The Breast Related Symptoms

Questionnaire (BRSQ) is a 13-item condition specific questionnaire which encompasses
both psychological and physical symptoms typically seen in women with breast
hypertrophy. In their study associated with the BRAVO (Breast Reduction: Assessment
of Value and Outcomes) study, Kerrigan et al found that women who presented for
surgical correction of their breast hypertrophy scored more poorly on the BRSQ than did
both the hypertrophy control subjects (bra cup size > D) and the normal control subjects
(bra cup size A, B, or C) [21]. Results from this extensive study suggest that symptoms
are a better indicator of which women have the greatest health burden than are physical
measurements such as breast volume.
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The data from all these studies clearly demonstrates that breast hypertrophy has a
significant impact on a women’s health-related quality of life and that symptoms of
breast hypertrophy are a legitimate indicator of medical necessity for reduction
mammaplasty surgery. More importantly, there is no evidence provided in these studies
that indicates that patient satisfaction or symptom improvement is enhanced with a
greater amount of tissue removed [12], further supporting the fact that reduction should
be considered a medically necessary procedure and not cosmetic in nature.
Alternatives to Reduction Mammaplasty
Insurance companies often require women who present with breast hypertrophy to
try other forms of nonsurgical pain treatment before they will cover the costs of surgery.
The length of time insurance companies require the patient to participate in nonsurgical
therapy for management of pain ranges from six weeks to six consecutive months [11,
31-34]. Common nonsurgical pain treatments include weight loss, aerobic exercise, use
of specialized support bras, stretching, strength exercises and postural training,
relaxation, heat application, hydrotherapy, back brace, medications, chiropractic
treatment, acupuncture and physical therapy. [1, 28].
While some nonsurgical treatments may provide temporary relief of pain, none of
these treatments have been shown to provide full operative relief to woman seeking
reduction mammaplasty surgery [28]. One of the most common nonsurgical treatments
many insurance companies require patients to try is weight loss due to their requirements
that patients be within 20% of ideal body weight prior to surgery [32]. This criterion is
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set under the premise that a lower body weight or body mass index will result in a greater
relief of symptoms. However, research evidence does not support this assumption as it
has been shown that symptom relief is independent of preoperative weight [14]. While
weight reduction alone may have an effect on the breast, it will not change body
proportion or breast position, and cannot therefore be expected to relieve symptoms of
breast hypertrophy [1]. The American Society of Plastic Surgeons states that despite the
fact that weight reduction may be beneficial to the patient’s overall health, it is not a prerequisite for reduction mammaplasty surgery [1], a statement clearly being overlooked by
insurance companies.
Other forms of nonsurgical treatments have also been shown to not provide full
relief of breast hypertrophy symptoms, and in some cases do not provide any relief.
Orthotic brassieres have been shown to provide some relief, but often substitute increased
discomfort in the shoulders through pressure created by the straps [1]. In the BRAVO
study conducted by Kerrigan et al, patients presenting for surgery were asked to report
any prior nonsurgical attempts to relieve their breast-related symptoms. The four most
common alternative treatments reported were weight loss, supportive bras, medications
and physical therapy [28]. Of the women surveyed, less than 1% found full permanent
relief with medications and heat applications and none reported full permanent relief with
other nonsurgical treatments [1, 28]. Also, over half of those women who had tried
several treatments, including weight loss, support bras, strengthening exercises and
postural training, reported no relief from these treatments [1, 28].
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Medical Coverage by Third Party Payers
Despite increasing recognition of breast hypertrophy as a morbid condition, there
is still great debate between plastic surgeons and insurance companies over when
reduction mammaplasty is considered medically necessary and therefore eligible for
insurance coverage. One foreseeable issue with determining medical necessity is that the
guidelines by which insurers determine eligibility for coverage of reduction
mammaplasty rely largely on subjective materials [35].

As a result, the criterion

insurance companies choose to use to determine coverage is often inconsistent resulting
in decisions for coverage that are not always equitable.
One criterion that is uniform across medical policies and consistent with the
definition of cosmetic surgery provided by the American Society of Plastic Surgeons is
that reduction mammaplasty will not be considered medically necessary when it is
performed solely for the purpose of treating psychological and psychosocial complaints
related to appearance [11, 31-33]. The American Society of Plastic Surgeons (ASPS)
states that justification for reduction mammaplasty should be based on the probability of
relieving the clinical signs and symptoms of macromastia. The ASPS also recommends
that coverage be based on documented symptoms of macromastia regardless of body
weight or weight of breast tissue removed [36].
Regardless of the ASPS recommendations and documentation by the American
Medical Association clearly defining the distinction between cosmetic and reconstructive
procedures, many insurance companies apply various criteria of their own in determining
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medical necessity. Most commonly, insurance companies establish a minimal amount of
breast tissue that must be removed in order to establish eligibility [1]. In a study done by
Krieger et al it was reported that sixty-nine percent of responding managed-care
organizations used weight of excised tissue as the primary criterion for coverage [37].
A meta-analysis of published studies found that a cut-off value of 350 grams is
one of the most common requirements for medical necessity by third-party payers [3].
However, Kerrigan et al reported that most insurance carriers use a 500g/breast tissue as
a cutoff irrespective of body habitus or patients’ presenting symptoms [20].

These

differences in reported criteria for minimum amount of breast tissue to be removed
support arguments by health care providers that using the weight of excised breast tissue
as a primary criterion for establishing medical necessity is arbitrarily based on
retrospective studies rather than scientific evidence.
Many insurance companies use the Schnur Sliding Scale as a standard tool to
determine medical necessity [3, 31, 32, 34, 38]. The Schnur sliding scale was developed
by Schnur et al in 1991 as an attempt to create a decision rule about the medical necessity
for reduction mammaplasty.

The scale proposes a “sliding” adjustment of required

resection weight of breast tissue to be removed based on a woman’s body surface area
[20].
The logic behind the Schnur sliding scale comes from physician’s opinions on
their patient’s motivation for surgery. The scale proposes that when the amount of breast
tissue to be removed compared to the woman’s body surface area lies above the 22nd
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percentile line the patient’s motivations are mostly functional and it should be considered
medically necessary for the patient to undergo reduction mammaplasty surgery.
However, when the amount of tissue to be removed falls below the fifth percentile line,
the model’s authors suggest that these women are seeking surgery for purely cosmetic
reasons. The authors also propose that women who fall in between the two lines have a
mixture of cosmetic and functional needs for the surgery and are considered on a case to
case basis [20, 35].
Despite the wide use of the Schnur sliding scale by insurance companies as a
criterion to determine the medical necessity of reduction mammaplasty, the legitimacy of
the scale has been questioned. Seitchik questioned Schnur’s work stating that it cannot
be assumed that patients registered below the fifth percentile were the same ones who
undertook surgery for only cosmetic reasons [35]. Based on a retrospective study of his
own patients, Seitchik concluded that a graded, three-level minimum specimen weight
standard would be more equitable for determining medical necessity [35]. However the
criteria developed in his study are much less restrictive than the 500g/breast minimum
rule used as a cutoff by many insurance carriers.
As part of the BRAVO study conducted by Kerrigan et al, researchers
investigated the scientific basis of both the Schnur sliding scale and the 500g/breast
minimum rule established by insurance companies. Findings from this study showed that
in women undergoing reduction mammaplasty, neither the Schnur siding scale nor the
500-g minimum rule was able to successfully predict which group of women would gain
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greater improvement from surgery as measured by 5 validated measures of health burden
[20]. As a result, Kerrigan et al concluded that the benefits of reduction mammaplasty
are not significantly associated with weight of resection, and recommended that breast
hypertrophy be defined by a breast volume in the top 10th percentile (>750cc) of the U.S.
population or a minimum bra cup size D[20, 28].
Spector et al published a study in 2007 supporting findings from the BRAVO
study that symptom improvement and patient satisfaction is independent of the amount of
breast tissue removed. In this study, patients were given a custom-designed questionnaire
designed to evaluate breast-hypertrophy related symptoms and quality of life factors
preoperatively and then given the same questionnaire at their final postoperative visit
three to twelve months after surgery. Results of this study showed that all 59 women
who had resection weights of less than 1000g showed significant decreases in breast
hypertrophy related symptoms analyzed including upper back pain, lower back pain, neck
pain, breast pain, headaches and shoulder pain.

These same women also showed

significant improvements in all quality of life factors analyzed including difficulty buying
clothes and bras, difficulty participating in sports, and difficulty running [39]. Spector et
al also did a second study on 188 patients in 2008 and found that prior to surgery, women
have the same symptom burden across all breast sizes and that the symptomatic
improvement derived from reduction mammaplasty is not significantly different between
women with different breast sizes [40].
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Summary
In summary, the task of defining medical necessity in the case of reduction
mammaplasty is complex. Most women who suffer from breast hypertrophy present with
similar physical and psychosocial symptoms and may also present with functional
disabilities due to improper positioning of the head and scapula. While there are many
nonsurgical treatment options available to help reduce symptoms of breast hypertrophy
reduction mammaplasty is the only treatment option shown to significantly improve
symptoms of breast hypertrophy. However, there is a lack of objective measurements
providing evidence of the medical necessity of reduction mammaplasty to relieve
symptoms of breast hypertrophy. As a result, insurance companies are forced to make
medical coverage decisions based on subjective evidence found in the medical literature.
In an attempt to provide scientific evidence of the medical necessity of reduction
mammaplasty to relieve symptoms of breast hypertrophy, the current study will
investigate the musculoskeletal burdens of breast hypertrophy in women who do not
present for reduction mammaplasty surgery. It is theorized that women with larger
breasts will exhibit both structural alterations and increased muscle activation due to the
size and position of their breasts in comparison to women with smaller breast sizes.
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METHODS
This chapter addresses the methodology and procedures used to accomplish the
objectives of this study. Topics to be outlined in this chapter will include: mathematical
definitions for all kinematic variables, equations for establishing local coordinate systems
for each body segment of interest, equations and definitions of muscle activation,
description of the health-measure instrument used, the experimental protocol, and the
statistical methods used to evaluate the significance of the resulting data from this study.
Kinematics
Previous research has shown that breast hypertrophy causes postural alterations
due to a change in the location of center of gravity [5,8]. Therefore, to fully understand
the burdens of breast hypertrophy on the skeletal system, it was necessary to quantify the
movements of the segments of the upper body during tasks of daily living. Kinematic
data of the upper body was tracked using a 6-camera optical motion camera system
(Vicon, 250 HZ). This system works by tracking the position of reflective spherical
surface markers mounted on the skin surface. For static calibration of the system, surface
markers were placed on anatomical landmarks of the head, scapula, thorax, and pelvis
(described below in anatomical surface marker section). In addition, a solid triad of
markers was placed on the scapula segment. Simultaneous acquisition of coordinate
systems for both the anatomically based landmarks of the scapula and the triad allowed
for removal of the anatomical markers of the scapula during trials, and improved
accuracy of the results.
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Kinematic Model
Kinematics of the upper body were quantified using a four-segment model
comprised of the head, scapula, thorax and pelvis. Kinematic data was obtained in order
to quantify movement in the head, thorax, pelvis, and scapula during each task of daily
living. Once this data is known, it can be compared to the same kinematic data for the
static trials in order to get an idea of the biomechanics of the upper body used to perform
each task of daily living.
Anatomically Based Landmarks
Local coordinate systems for each segment were established by placing surface
markers over at least three anatomically based landmarks in each segment. The locations
of the markers for the head, thorax, pelvis and scapula are as follows:


Head (Figure 1.)
o Left front head (LFHD): Point of the left anterior side of the head
o Right front head (RFHD): Point of the right anterior side of the head
o Left back head (LBHD): Point of the left posterior side of the head
o Right back head (RBHD): Point of the right posterior side of the head
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RBHD

LBHD

RFHD
LFHD

Figure 1. Location of Head Markers


Thorax (Figure 2.)
o Seventh Cervical Vertebrae (C7): Spinous process of the seventh cervical
vertebrae
o Sixth Thoracic Vertebrae (T6): Spinous process of the sixth thoracic
vertebrae
o Twelfth Thoracic Vertebrae (T12): Spinous process of the twelfth thoracic
vertebrae
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C7
T6
T12

Figure 2. Location of Thorax Markers



Pelvis (Figure3.)
o Left Anterior Superior Iliac Spine (LASI): Anterior extremity of the iliac
crest of the pelvis on the left side
o Right Anterior Superior Iliac Spine (RASI): Anterior extremity of the iliac
crest of the pelvis on the right side
o Left Posterior Superior Iliac Spine (LPSI): Posterior extremity of the iliac
crest of the pelvis on the left side
o Right Posterior Superior Iliac Spine (RPSI): Posterior extremity of the
iliac crest of the pelvis on the right side
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Figure 3. Location of Pelvic Markers (Inferior View)



Scapula (Figure 4.)
o Trigonum Spine (TS): Midpoint of the triangular surface on the middle
border of the scapula, in line with the scapular spine
o Angulus Acromialis (AA): The most laterodorsal point of the scapula
o Inferior Angle (AI): The most caudal point of the scapula
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AA
TS

AI

Figure 4. Location of Scapula Markers (Posterior View)

Local Coordinate Systems
With at least three known anatomically based coordinates, a local coordinate
system can be established for each body segment of interest. The methods used to create
local coordinate systems for the head, thorax, pelvis and scapula is described below.


Head (Figure 5): The origin of the head coordinate system (H0) was located at the
center of the head. The location of H0 was calculated by calculating the midpoint
of the line connecting the midpoint of the two anterior markers (LFHD and
RFHD) and the two posterior markers (LBHD and RBHD) using the following
equations:
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o Midpoint (HF) of the two anterior markers (LFHD and RFHD)
HF = (LFHD+RFHD)/2
Equation 1.
o Midpoint (HB) of the two posterior markers (LBHD and RBHD)
HB = (LBHD+RBHD)/2
Equation 2.
o Location of the origin (H0)
H0 = (HF + HB)/2
Equation 3.
The x-axis (HX) of the head coordinate system was a unit vector pointing in the
anterior direction from H0 to HF.
HX =

H F  H 0 
H F  H0

Equation 4.
The z-axis (HZ) of the head coordinate system was a unit vector pointing in the
superior direction and was the cross product of HX and a unit vector pointing from
H0 to LFHD.
HZ =

H X  LFHD  H 0 
H X  LFHD  H 0 
Equation 5.
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Finally, the y-axis (HY) of the head coordinate system was a unit vector pointing
to the left, and was the cross product of HZ and HX.
HY =

HZ  H X
HZ  H X

Equation 6.

HZ
RBHD

Ho

HY

LBHD

HXY

RFHD
LFHD

Figure 5. Head Coordinate System


Thorax (Figure 6.): The origin of the thorax coordinate system (T0) was located
at the twelfth thoracic vertebrae (T12). The z-axis (TZ) of the thorax coordinate
system was a unit vector pointing in the superior direction from T0 to the seventh
cervical vertebrae (C7).
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TZ =

C7  T0 
C7  T0

Equation 7.
The y-axis (TY) of the thorax coordinate system was a unit vector pointing to the
left and was the cross product of a unit vector pointing from C7 to T6 and TZ.
TY =

T6  C 7  TZ
T6  C 7  TZ
Equation 8.

Finally, the x-axis of the thorax coordinate system was a unit vector pointing in
the anterior direction and was the cross product of TY and TZ.
TX =

TY  TZ
TY  TZ

Equation 9.
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Tz
TY

 C7
 T6
 T12

TX
Figure 6. Thorax Coordinate System


Pelvis (Figure 7.): The origin of the pelvic coordinate system (P0) was located at
the center of the pelvis. The location of P0 was calculated by calculating the
midpoint of the line connecting the midpoint of the two anterior markers (LASI
and RASI) and the two posterior markers (LPSI and RPSI) using the following
equations:
o Midpoint (MA) of the two anterior markers (LASI and RASI)
MA = (LASI+RASI)/2
Equation 10.
o Midpoint (MP) of the two posterior markers (LPSI and RPSI)

32

MP = (LPSI+RPSI)/2
Equation 11.
o Location of the origin (P0)
P0 = (MA + MP)/2
Equation 12.
The x-axis (PX) of the pelvis coordinate system was a unit vector pointing in the
anterior direction from P0 to MA.
PX =

M A  P0 
M A  P0

Equation 13.
The z-axis (PZ) of the pelvis coordinate system was a unit vector pointing in the
superior direction and was the cross product of P X and a unit vector point from P0
to LASI.
PZ =

PX  LASI  P0 
PX  LASI  P0 
Equation 14.

Finally, the y-axis (PY) of the pelvis coordinate system was a unit vector pointing
to the left, and was the cross product of PZ and PX.
PY =

PZ  PX
PZ  PX

Equation 15.
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RPSI

LPSI

LASI
RASI

Figure 7. Pelvic Coordinate System


Scapula (Figure 10.): As described earlier, a triad was placed on the scapula
segment during data collection in order to better facilitate data collection of the
scapular region. Use of the triad required the establishment of a triad coordinate
system. A rotation matrix was used to align the triad coordinate system with the
anatomical coordinate system for the scapula in order to calculate joint angles of
the scapula during dynamic trials. This allowed for the points of the scapula to be
located during the dynamic trials even though the anatomical markers were not
present. Please refer to the diagram of the triad in Figure 8 for the following
equations.
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Figure 8. Scapula Triad
The y-axis of the triad coordinate system (TrY) was a unit vector pointing from T3
to T1.
TrY =

T1  T3 
T1  T3

Equation 16.
The z-axis of the triad coordinate system (TrZ) was a unit vector pointing in the
superior direction perpendicular to the plane formed by triad markers T 1, T2, and
T3. This was found by taking the cross product of TrY and a unit vector pointing
from triad marker T3 to triad marker T2.
TrZ =

TrY  T2  T3 
TrY  T2  T3 

Equation 17.
Finally, the x-axis of the triad coordinate system (TrX) was a unit vector pointing
in the anterior direction and was the cross product of TrY and TrZ.
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TrX =

TrY  TrZ
TrY  TrZ

Equation 18.
TrY
TrZ

TrX

Figure 9. Triad Coordinate System
The first step in aligning the triad coordinate system with the anatomical
coordinate system of the scapula was to establish the unit vector matrix for the
triad [UTRI].
[UTRI] = [TrX´ TrY´ TrZ´]
Equation 19.
Next, the scapula anatomical markers were located using data from the static trial.
Anatomical marker offsets for AA, TS, and AI (S1, S2, and S3, respectively)
represent the distance from the anatomical marker to the origin of the triad (T2).
Once these anatomical markers were located, they were then rotated into the
global coordinate system (UG).
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o Location of AA
AA = T2  U G  UTRI   S1
Equation 20.
o Location of TS
TS = T2  U G  U TRI   S2
Equation 21.
o Location of AI
AI = T2  U G  U TRI   S3
Equation 22.
Based on data from the triad (see equations 20-22) a new scapula coordinate
system was created with its origin at AA. The y-axis of the scapula coordinate
system (SY) was a unit vector pointing from AA to TS.
SY =

TS  AA
TS  AA

Equation 23.
The x-axis of the scapula coordinate system (SX) was a unit vector pointing in the
anterior direction and perpendicular to the plane formed by scapula markers AA,
TS, and AI. This was found by taking the cross product of a unit vector pointing
from AA to AI and SY .
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SX =

 AI  AA  SY
 AI  AA  SY

Equation 24.
Finally, the z-axis of the scapula coordinate system (SZ) was a unit vector
pointing in the superior direction and was the cross product of SX and SY.
SZ =

S X  SY
S X  SY

Equation 25.

Sz
Sx

Sy

•AA-Angulus Acromialis
•TS-Trigonum Spinae
•AI-Angulus Inferior

Figure 10. Scapula Coordinate System

38

Rotation Sequences for Each Body Segment
In order to calculate the segment angles of interest, rotation matrices for each
segment were created.


Head rotation matrix
[RH] = [HX´ HY´ HZ´]
Equation 26.



Thorax rotation matrix
[RT] = [TX´ TY´ TZ´]
Equation 27.



Pelvis rotation matrix
[RP] = [PX´ PY´ PZ´]
Equation 28.



Scapula rotation matrix
[RS] = [SX´ SY´ SZ´]
Equation 29.
Euler angles were then calculated in order to quantify the orientation of one

segment relative to another segment. The orientation of the pelvis (RPelvis) was defined
relative to the global coordinate system and was the product of the inverse of the pelvis
rotation matrix [RP] and the global coordinate system matrix [UG ].
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RPelvis = invRP   U G 
Equation 30.
The orientation of the torso (RTorso) was defined relative to the pelvis (RPelvis) and was the
product of the inverse of the torso rotation matric [RT] and the pelvis rotation matrix [RP].
RTorsos = invRT   RP 
Equation 31.
The orientation of the scapula (RScap) was defined relative to the torso (RTorso) and was the
product of the inverse of the scapula rotation matrix [RS] and the torso rotation matrix
[RT].
RScap = invRS   RT 
Equation 32.
Finally, the orientation of the head (RHead) was defined relative to the torso (RTorso) and
was the product of the inverse of the head rotation matrix [RH] and torso rotation matrix
[RT].
RHead = invRH   RT 
Equation 33.
In this study, the sagittal plane was the primary plane of movement (movement
about the y-axis). Therefore, rotations were conducted in the following order to ensure
accuracy in the calculations of movement occurring in the sagittal plane: Y-axis, X-axis,
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Z-axis.

Euler angles for each segment were extracted from the unit vector matrix

associated with that segment using the following equations


Movement about the Y-axis
  R32 

  tan 1 
 R33 

Equation 34.


Movement about the X-axis

  sin 1 R31 
Equation 35.


Movement about the Z-axis
  R21 

  tan 1 
 R11 

Equation 36.

For the head and thorax α, β, and γ correspond to flexion/extension, lateral
flexion, and rotation, respectively. For the pelvis, α, β, and γ correspond to tilt, lateral
flexion and internal/external rotation, respectively.

For the scapula, α, β, and γ

correspond to tilt, upward rotation, and protraction/retraction, respectively.
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Electromyography
Postural alterations due to heavy breast tissue may cause strain on the cervicothoracic muscles, thus inducing muscle weakness of these important upper body postural
muscles. In order to examine the effects of excess breast tissue mass on cervico-thoracic
muscle

activation,

electromyographic

data

of

the

muscles

associated

with

musculoskeletal pain in the neck, back and shoulder regions was obtained using a
wireless surface electromyography (sEMG) system (BTS Engineering FreeEMG, 1000
Hz). This system works by using wireless technology to detect muscle activation via
individual sensors placed over the muscle of interest. This section will address the
placement of the electrodes, processing of the raw signals, and the quantification of the
amplitude of muscle activation for all five muscles of interest as a percentage of MVC.
Electrode Placement
Prior to placement of individual EMG sensors on the subject, the subject’s skin
was abraded and cleaned with alcohol in order to reduce skin impedance. Pre-gelled
silver-silver chloride bipolar electrodes with the wireless EMG sensors attached were
then placed on each of the five muscles of interest according to the methods described by
Cram (Table 1 below and Figures B1-B5 in Appendix B) [41].
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Table 1. Surface Electrode Placement
Muscle

Placement
Placed two centimeters away from the spine and parallel with the

Midcervical (C4) Paraspinal

muscle fibers over the muscle belly at approximately the fourth
cervical vertebrae (C-4)

Placed running parallel with the muscle fibers along the ridge of the
Upper
shoulder, slightly lateral to and onehalf the distance between the
Trapezius
seventh cervical vertebrae (C-7) and the acromion
Placed at an oblique angle, approximately five centimeters down
Lower
from the scapular spine and placed next to the medial edge of the
Trapezius
scapula at a 55-degree angle
Serratus

Placed horizontally just below the axillary area, at the level of the

Anterior

inferior tip of the scapula, and just medial of the latissimus dorsi.
Placed parallel to the spine, approximately two centimeters from the

Low Back
spine and placed over the muscle mass. Subjects were in a slight
(Erector Spinae)
forward flexion for electrode placement.
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Maximum Voluntary Contraction Protocol
To define the maximal exertion of the muscles of interest, a maximum voluntary
contraction (MVC) was obtained for each muscle. The exercise chosen to obtain the
MVC for each muscle of interest was the superman exercise, in which the chest, arms,
and legs are simultaneously raised as high off the table as possible (Figure 11).
Each subject was instructed to lie in a prone position on an examination table with her
arms stretched out in front. The subject was then strapped to the table with one strap
across the top of the shoulders and a second strap just above the knees in order to provide
resistance to the subject during the exercise. Each subject performed five repetitions of
the MVC and the average maximum EMG signal during the contraction was used to
normalize the tasks of daily living EMG signals.

Figure 11. The Superman Exercise

Initial Signal Processing
EMG data was obtained via surface electromyography. EMG signals from each
muscle were sampled at 1000 Hz via individual EMG sensors placed over the muscles of
the neck, upper thorax, and low back (described above in Table 1) during each activity of
daily living (described below in the experimental protocol section). Data was rectified
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and smoothed using a root mean square algorithm with a 20-ms moving window and
normalized to the MVC as a percentage of effort.
To find the percent muscle activation of each of the five muscles of interest, the
peak EMG signal for each muscle was found using custom Matlab software. This
maximum peak was used to establish a ratio of upper body posture muscle activation to
MVC muscle activation, resulting in a ratio of percent effort ranging from 0-100%.
 A

% Muscle Activation =  muscle   100
 MVCmuscle 

Equation 37.
In the above equation, Amuscle represents the peak amplitude of the individual muscle
activation during each task of daily living, and MVCmuscle represents the peak amplitude
of the individual muscle activations during the MVC exercise.
Health-Related Quality of Life
Women who present with breast hypertrophy typically exhibit poorer scores on
health-related quality of life instruments [2, 14, 21, 28, 29]. Although the main focus of
this study is the biomechanical effects of breast hypertrophy on the spine and cervicothoracic muscle activation, it was important to assess each subject’s health-related quality
of life status in order to establish relationships between the biomechanical data from this
study and the health-related quality of life data presented in previous studies.
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Health-Measure Instrument
The Breast Related Symptoms Questionnaire (BRSQ) was administered to each
subject in order to determine the severity of the pain associated with breast hypertrophy
each subject is experiencing (See Appendix A). The BRSQ is a 13 item condition
specific instrument developed by Kerrigan et al in 2001 in order to systematically
quantify breast-specific symptoms [21]. A breast symptom summary score (BSS) was
computed by averaging the item scores and linearly transforming the average to a 0-to100 scale. For this instrument, higher summary scores correspond to fewer and less
severe systems. This instrument has undergone test-retest reliability and has face validity
[20, 21].
Experimental Protocol
All subjects for this study were women over the age of 18 who have never
undergone or been approved for breast augmentation surgery (N=26). All subjects were
recruited from the general student, faculty and staff population at Boise State University.
Participation in this study was strictly voluntary, and subjects were free to discontinue
their participation in this study at any time during the data collection session. This study
was approved by the Institutional Review Board at Boise State University prior to
initiation of subject recruitment.
All testing was conducted at the Intermountain Orthopaedics Sports Medicine and
Biomechanics Research Laboratory on the campus of Boise State University in Boise,
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Idaho. Upon arrival to the lab, each subject read and signed the informed consent
document prior to participation in the study and was given a copy for their records.
Once the informed consent had been signed, each subject completed the Breast
Related Symptoms Questionnaire. Subjects were allowed to fill out this questionnaire
independently with the principal investigator present in order to answer any questions
that the subject may have had.
Following completion of the Breast Related Symptoms Questionnaire, descriptive
data for each subject was obtained for each individual by the principal investigator and a
research assistant. The data obtained included: age, height, weight, self-reported bra cup
size, type of bra worn for testing, and sternal notch to nipple distance. Each subject’s
height (meters) and weight (kilograms) was used to calculate her Body Mass Index
(BMI) using the following formula:

BMI =

weight (kg )
height (m) 2

Equation 38.
Once all the descriptive data had been obtained, each subject was prepared with
spherical surface markers and EMG electrodes for biomechanical data collection (as
described above in kinematic and muscle activation section, respectively). Subjects were
asked to perform testing while wearing a tank top so that surface markers and sEMG
electrodes could be placed directly on the skin surface when appropriate (See Appendix
C for pictures of complete subject setup). Once all the surface markers and sEMG
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electrodes were in place, a static image of the subject was obtained using the VICON
optical motion capture system.

Once the static image was obtained, the anatomically

based markers on the scapula were removed (as described above in the Kinematics
section and seen below in Figures 12 and 13).

Figure 12. Scapula Marker Set up during the Static Image
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Figure 13. Anatomically Based Scapula Markers Removed
In order to get an idea of the kinematics of the upper body and the amount of
muscle activation each subject used while in their natural standing postural alignment,
static posture measurements were obtained before and after the four tasks of daily living
had been completed. To obtain static posture, subjects were instructed to place their
hands on their hips and adopt a comfortable and natural standing position as if no one
was watching them [25]. Once in this position subjects were instructed to remain as still
as possible and to count backwards from fifty. Static positions of each of the surface
markers, and static values for muscle activation were captured for two 3-5 second
intervals both before and after the four tasks of daily living had been completed (Figure
14).
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Figure 14. Standing Position of Subject during Static Posture Measurements
Kinematics of the upper body as well as muscle activation was measured while
the subject performed four different tasks of daily living. Each subject performed a series
of 5-10 trials of each of the four tasks of daily living with approximately 30-45 seconds
of rest in between each trial and 1-2 minutes of rest between each task. The tasks were
performed in random order and included:


Picking a pencil off the ground: Subjects were instructed to begin the exercise
with their hands on their hips and reach down to pick up a pencil off the floor as
they normally would as if they had dropped it. Subjects were also instructed to
place their hands back on their hips following the completion of the task.
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Sitting down and standing up from a stool: Subjects were asked to place their
hands on their hips throughout the duration of the task as they sat down and then
stood up from a stool.



Stepping on and off a six inch tall platform: Subjects were instructed to step on
and off the platform leading with their right leg and keeping their hands on their
hips throughout the duration of the task.



Lifting a milk jug filled with 9.75 pounds of sand overhead: Subjects were
instructed to begin the exercise with their hands on their hips, and then reach
down and pick up the weighted milk jug with their right hand. Once they had
picked up the jug, each subject used their left hand to help guide the jug to a point
overhead, and then lowered the jug back down. Subjects were also instructed to
place their hands back on their hips following the completion of the exercise.

Once all the trials had been completed, the electrodes and surface markers were removed
by the principal investigator and research assistants.
Statistics
All statistical analysis was completed using Microsoft Excel 2003 for Windows.
To compare muscle activation and kinematic variables across the four tasks of daily
living, and BSS scores between subjects, a two-tailed independent t-test was performed
for each dependent variable of interest.

Power analysis was performed for each

dependent variable’s t-test using an online statistics toolkit (provided by DSS Research)
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in order to get an idea of the probability of making a type II error (β). For the purposes of
this study, p values less than 0.05 were considered to be statistically significant.
Due to the small size of the subject population and the possibility of slight
variations in how each subject chose to perform each task of daily living, an outlier test
was performed on all data collected in order to account for any extreme skews in the
distribution. In order to identify possible outliers in the data set, the interquartile range
(IQR) was computed for each dependent variable. Data points found to be three times the
IQR less than the first quartile or three times the IQR greater than the third quartile were
considered outliers and were not included in the final data analysis.

Data points

associated with muscle activation were also excluded from the final data if %MVC
values during tasks of daily living produced negative results since that would indicate
that the subject used greater than their maximum effort to complete the given task.
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RESULTS
This section contains all the results from the data collection and analysis
previously described.

This includes demographic information of the participating

subjects and comparison of breast summary scores (BSS), muscle activation and upper
body kinematics between normal control subjects and breast hypertrophy subjects. A
total of 26 subjects participated in this study. However, only 22 subjects were used in the
final analysis due to insufficient data from four participants. All subjects were recruited
from the female population of students and faculty at Boise State University and had no
history of breast augmentation surgery.
Three subjects from the normal control group were not included in the lift trial
results and one subject from the normal control group was not included in the step up trial
results because the electromyography data did not match up with the kinematic data. As
a result, the normal control group data set consisted of 608 data points and the
hypertrophy group data set consisted of 540 data points before statistical analysis took
place.
As mentioned above in the methods section, any negative %MVC values and
extreme outliers were removed from the data sets. Out of 608 data points for the normal
group, fourteen data points were removed for being negative %MVC values and fifteen
data points were removed for being extreme outliers for a total of 4.76% of points
removed from the normal control group data set.

Out of 540 data points for the

hypertrophy group, twelve data points were removed for being negative %MVC values,
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and fifteen data points were removed for being extreme outliers for a total of 5.00% of
points removed from the hypertophy group data set.
Demographics
Of the 22 subjects analyzed, 12 were in the normal control group (self-reported
bra cup sizes A – C), and 10 were in the hypertrophy group (self-reported bra cup size >
D). Distribution of self-reported bra cup sizes is shown in Figure 15. The average age of
the normal control and hypertrophy subjects was 24.4 (±4.1 yrs, range 20-34), and 26.1
(±6.7 yrs, range 21-40), respectively.
Distribution of Bra Cup Sizes

Number of Subjects

7
6
5
4
3
2
1
0
A Cup

B cup
Normal Control Group

C Cup

D Cup

DD Cup

F Cup

G Cup

Hypertrophy Group

Figure 15. Subject Distribution by Group and Bra Cup Size
Subject demographics for the two groups are given in Table 2. Statistical analysis
of the subject demographics revealed significant differences in height (p=0.003), BMI
(p=0.009), left SNTND (p=0.004), and right SNTND (p=0.000) between the two groups.
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Table 2. Subject Demographics
Normal
Control Hypertrophy p value Power
Mean
1.73
1.64
Height
0.003* 0.778
Std
±0.10
±0.44
(m)
Dev
Mean 71.00
77.60
Weight
0.322
0.299
Std
±10.0
±11.34
(kg)
Dev
Mean 23.92
28.84
BMI
0.009* 0.873
Std
±3.62
±3.78
(kg/m2)
Dev
Mean 15.23
18.65
Left
0.004* 0.968
Std
±1.23
±2.60
SNTND
Dev
Mean 14.75
18.36
Right
0.005* 0.992
Std
±1.11
±2.41
SNTND
Dev
*Statistically significant p<0.05

BRSQ Scores
The Breast Related Symptoms Questionnaire (BRSQ) is a validated instrument
used to evaluate the severity of breast-related symptoms.

The BSS is a linearly

transformed average of the responses given on the BRSQ, and is used to quantify the
burdens of breast hypertrophy with lower scores being indicative of an increase in the
severity of breast-related symptoms. Data from the BRSQ for both subject groups is
shown in Table 3. Women in the normal control group scored significantly higher
(p=0.005) on the BRSQ, indicating a lesser severity of breast-related symptoms.
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Table 3. BRSQ Scores
Standard
Deviation Power

Group
BSS
Normal
Control
99.13
1.32
Hypertrophy 71.54
19.75
*Statistically significant p<0.05

0.993

Kinematic Results
Upper body kinematics of the head, thorax, pelvis and scapula were quantified in
order to get a better understanding of the effect of breast size on the musculoskeletal
system. Specifically, head flexion, torso flexion and extension, lateral torso extension,
scapular protraction, scapular upward rotation, and pelvic tilt were analyzed for static
trials and for each task of daily living.
For analysis purposes, two static trials from the beginning of the data collection
and two static trials from the end of the data collection were used to create an “average
static posture” for each subject. Subject movement was normalized to static posture by
subtracting the “average static posture” from the average maximum kinematic values for
each task, thus allowing movement variables between subjects to be compared.
Static Posture
Static trial data was collected before and after the four tasks of daily living had
been completed. Group averages of average static posture measurements for normal
control subjects and hypertrophy subjects are shown in Figure 16.
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Average Static Posture
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Figure 16. Group Average Static Posture Variables
Average static posture values for both groups are shown in Table 4. Statistical
analysis revealed no significant differences in average static posture between groups.
However, it is important to note that anterior pelvic tilt is approaching significance
(p=0.098) during static posture measurements.
Table 4. Average Static Posture

Head
Flexion (+)
Mean
13.87º
Normal
Std
Control
Dev
± 7.45 º
Mean
15.63 º
Std
Hypertrophy Dev
± 5.70 º
0.839
p-value
0.097
Power
Group

Anterior
Pelvic
Tilt (+)
5.95 º

Scapular
Protraction
(+)
31.58 º

Scapular
upward
rotation
(+)
16.10 º

Torso
flexion
(+)
9.64º

± 4.19 º
11.51 º

± 13.85º
23.94 º

± 27.18 º
8.85º

± 4.63º
13.85º

± 7.73 º
0.097
0.532

± 11.74º
0.13
0.288

± 21.23 º
0.354
0.108

± 8.04º
0.23
0.311
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Head Flexion
Head flexion data for the pencil, sit, step up, and lift tasks for both normal control
and hypertrophy subjects are shown in Table 5. Normal control subjects appear to
present with more head flexion while performing tasks of daily living.

However,

statistical analysis provided no significant differences between the two groups during
these tasks.
Table 5. Head Flexion During Tasks of Daily Living

Task
Pencil
Sit
Step Up
Lift

Mean
Std
Dev
Mean
Std Dev
Mean
Std Dev
Mean
Std Dev

Normal
Control
35.70º
±11.16º
20.48º
±6.55º
5.29º
±7.21º
26.18º
±14.02º

Hypertrophy
30.18º
±9.32º
15.11º
±12.17º
4.59º
±4.81º
16.21º
±7.13º

p value

Power

0.484

0.244

0.206

0.240

0.741

0.059

0.325

0.576

Pelvic Tilt
Data regarding the average amount of pelvic tilt occurring during the four tasks of
daily living is provided in Table 6. For 3 of the 4 activities of daily living, hypertrophy
subjects appear to present with more anterior pelvic tilt. Despite visual differences,
statistical analysis showed no significant differences between the two groups during the
four tasks of daily living. However, the difference in pelvic tilt during the sit exercise
appears to be approaching significance (p = 0.091).
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Table 6. Pelvic Tilt During Tasks of Daily Living

Task
Pencil
Sit
Step Up
Lift

Mean
Std Dev
Mean
Std Dev
Mean
Std Dev
Mean
Std Dev

Normal
Control
27.18º
±3.30º
11.59º
±6.10º
8.01º
±3.09º
8.82º
±4.12º

Hypertrophy
28.27º
±12.15º
17.11º
±7.74º
10.63º
±4.90º
6.29º
±6.92º

p value

Power

0.296

0.059

0.091

0.449

0.123

0.311

0.527

0.174

Scapular Movements
The main movement of interest for the scapula was scapular protraction, except
for in the lift task in which upward rotation of the scapula was examined. Data for the
scapula movement during the four tasks of daily living is provided in Table 7. Statistical
analysis of the movements of the scapula during all four tasks of daily living showed no
significant differences between the normal control group and the hypertrophy group.
Table 7. Scapula Movement During Tasks of Daily Living
Normal
Task
Control
Hypertrophy
22.99º
22.15º
Mean
Pencil
Std Dev
±15.99º
±24.30º
6.22º
8.40º
Mean
Sit
Std Dev
±7.70º
±4.87º
10.19º
8.09º
Mean
Step Up
Std Dev
±7.93º
±5.39º
Mean
7.21º
4.53º
Lift#
Std Dev
±7.03º
±4.09º
#Scapular Upward Rotation measured during lift trials

p value Power
0.914

0.051

0.317

0.057

0.545

0.114

0.450

0.199
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Torso Flexion
Torso flexion was analyzed across all four tasks of daily living, except for in the
lift task which torso extension was the variable of interest. During the lift task, lateral
torso flexion (Lift 2) was also analyzed in order to investigate the role of the spine in the
biomechanics of the shoulder during an overhead activity (positive values represent
flexion of the spine towards the left side of the body). Average torso flexion values for
both subject groups during the four tasks of daily living are shown in Table 8. Visual
analysis of the data indicates that normal control subjects exhibited greater amounts of
torso flexion during pencil, sit, and step up tasks. Statistical analysis of torso flexion
showed significant differences in the average amount of torso flexion during the pencil
and step up tasks (p= 0.055 and 0.001, respectively). Conversely, hypertrophy subjects
exhibited slightly greater mounts of torso extension and lateral torso flexion during the
lift tasks. However, neither of these differences seen was statistically significant.
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Table 8. Torso Movement During Tasks of Daily Living
Normal
Control
Task
Hypertrophy p value Power
53.40º
40.76º
Mean
Pencil
0.055* 0.675
Std Dev
±10.87º
±13.25º
19.31º
14.87º
Mean
Sit
0.093
0.223
Std Dev
±7.71º
±9.40º
15.21º
6.04º
Mean
Step Up
0.001* 0.993
Std Dev
±4.72º
±4.99º
Mean
6.12º
10.14º
Lift#
0.190
0.349
Std Dev
±3.11º
±7.59º
Mean
1.84º
1.88º
Lift 2##
0.410
0.050
Std Dev
±1.62º
±1.91º
#Values represent amount of torso extension during lift trials
##Values represent lateral torso flexion during lift trials
*Statistically significant p<0.05

Muscle Activation
The amount of muscle activation (expressed as %MVC) exhibited by a particular
muscle provides information about the amount of work the muscle of interest is
performing.

It has been hypothesized that pain in the neck, back and shoulders

symptomatic of breast hypertrophy may be due to increased tension (activation) of the
cervico-thoracic muscles.
This study specifically examined muscle activation of the Midcervical (C-4)
paraspinal, upper trapezius, lower trapezius, serratus anterior, and the low back (Erector
Spinae) during static posture trials and tasks of daily living. All electromyography data
matches up with the movement trials used in the kinematic analysis.
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For analysis purposes, two static trials from the beginning of the data collection
and two static trials from the end of the data collection were used to create “average static
muscle activation” for each subject. Subject movement was normalized to static posture
by subtracting the “average static muscle activation” from the average muscle activation
values for each task, thus muscle activation between subjects to be compared.
Static Posture
Data was collected for static trials before and after the tasks of daily living were
completed. The muscle activation of the five muscles of interest during static posture
trials is shown in Table 9. Group averages of average static posture measurements for
normal control subjects and hypertrophy subjects are shown in Figure 17.
Average Static Muscle Activation
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%MVC
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15.00%
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10.00%

Hypertrophy

5.00%
0.00%
-5.00%
-10.00%
-15.00%
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Upper
Trapezius

Lower
Trapezius

Serratus
Anterior

Erector
Spinae

Muscle

Figure 17. Group Averages for Muscle Activation
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Table 9. Static Muscle Activation

Mean
Std Dev

Normal
Control
(%MVC)
6.10%
±4.03%

Mean
Std Dev

5.23%
±3.11%

13.04%
±14.03%

0.123

0.407

Mean
Std Dev

3.12%
±1.39%

6.35%
±5.04%

0.051*

0.502

Mean
Std Dev

6.64%
±3.39%

9.23%
±5.00%

0.075

0.286

Mean
6.52%
Std Dev
±3.90%
*Statistically significant p<0.05

10.62%
±4.86%

0.115

0.576

Muscle
Midcervical
Upper
Trapezius
Lower
Trapezius
Serratus
Anterior
Erector
Spinae

Hypertrophy
(%MVC)
p value Power
7.62%
0.582
0.170
±3.30%

Analysis of static muscle activation shows that hypertrophy subjects exhibited
higher percentages of muscle activation during static posture trials. Statistical analysis
indicates a significant difference in the level of muscle activation of the lower trapezius
(p = 0.051).
Pencil Task
Average muscle activation values for the pencil task are shown in Table 10.
Hypertrophy subjects exhibited greater amounts of muscle activation for all five muscles
during the pencil task. However, statistical analysis showed no significant differences in
the levels of muscle activation between the two subject groups during this task.
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However, the difference in lower trapezius muscle activation between groups appears to
be approaching significance.
Table 10. Muscle Activation during the Pencil Task

Mean
Std Dev

Normal
Control
(%MVC)
3.12%
±1.85%

Mean
Std Dev

8.94%
±9.88%

12.75%
±16.73%

0.741

0.097

Mean
Std Dev

2.54%
±2.59%

3.24%
±3.40%

0.071

0.083

Mean
Std Dev

2.50%
±2.81%

3.39%
±2.21%

0.765

0.132

Mean
2.04%
Std Dev
±1.09%
*Statistically significant p<0.05

2.35%
±2.08%

0.687

0.071

Muscle
Midcervical
Upper
Trapezius
Lower
Trapezius
Serratus
Anterior
Erector
Spinae

Hypertrophy
(%MVC)
p value Power
7.91%
0.168
0.375
±9.08%

Sit Task
Muscle activation levels of the five muscles of interest during the sit task are
provided in Table 11. Hypertrophy subjects exhibited greater muscle activation in all
muscles except the upper trapezius during the sit task. However, statistical analysis
revealed no significant differences between the %MVC means of the normal control and
hypertrophy group for this task.
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Table 11. Muscle Activation during the Sit Task

Mean
Std Dev

Normal
Control
(%MVC)
3.20%
±3.25%

Mean
Std Dev

5.75%
±5.43%

2.97%
±2.06%

0.114

0.373

Mean
Std Dev

0.91%
±0.57%

1.24%
±0.53%

0.578

0.290

Mean
Std Dev

2.71%
±2.63%

4.37%
±3.45%

0.426

0.239

Mean
1.24%
Std Dev
±0.55%
*Statistically significant p<0.05

1.64%
±0.76%

0.410

0.284

Muscle
Midcervical
Upper
Trapezius
Lower
Trapezius
Serratus
Anterior
Erector
Spinae

Hypertrophy
(%MVC)
p value Power
3.39%
0.738
0.053
±2.71%

Step Up
Muscle activation levels of the five muscles of interest during the step up task are
provided in Table 12. Hypertrophy subjects exhibited greater levels of muscle activation
in the midcervical, lower trapezius, serratus anterior, and erector spinae during the step
up task. However, statistical analysis yielded no significant differences between the
%MVC means of the normal control and hypertrophy groups for this task.
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Table 12. Muscle Activation during the Step Up Task

Mean
Std Dev

Normal
Control
(%MVC)
4.42%
±4.36%

Mean
Std Dev

5.12%
±3.09%

2.46%
±0.95%

0.139

0.776

Mean
Std Dev

0.96%
±0.55%

5.94%
±0.55%

0.104

0.544

Mean
Std Dev

3.75%
±2.44%

3.95%
±2.74%

0.577

0.054

Mean
1.99%
Std Dev
±1.00%
*Statistically significant p<0.05

3.72%
±2.33%

0.239

0.589

Muscle
Midcervical
Upper
Trapezius
Lower
Trapezius
Serratus
Anterior
Erector
Spinae

Hypertrophy
(%MVC)
p value Power
5.95%
0.815
0.116
±5.11%

Lift Task
Muscle activation levels of the five muscles of interest during the step up task are
provided in Table 13. Statistical analysis of the muscle activation levels during the lift
task showed no significant differences between the two groups. However, it is important
to note that hypertrophy subjects exhibited greater muscle activation in the lower
trapezius, serratus anterior and erector spinae than the normal control subjects while
performing this task
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Table 13. Muscle Activation during the Lift Task

Mean
Std Dev

Normal
Control
(%MVC)
8.62%
±4.72%

Upper
Trapezius

Mean
Std Dev

27.57%
±26.19%

16.27%
±13.86%

0.241

0.253

Lower
Trapezius

Mean
Std Dev

3.32%
±1.96%

5.12%
±6.37%

0.365

0.139

Serratus
Anterior

Mean
Std Dev

4.69%
±2.80%

6.33%
±4.70%

0.590

0.163

Mean
4.79%
Std Dev
±2.86%
*Statistically significant p<0.05

5.22%
±4.30%

0.481

0.058

Muscle
Midcervical

Erector
Spinae

Hypertrophy
(%MVC)
p value Power
6.65%
0.315
0.175
±4.92%
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DISCUSSION
The purpose of this study was to investigate biomechanical differences in the
upper body of women with larger breast sizes in order to provide evidence of the
musculoskeletal burdens of breast hypertrophy. In this study, women were divided into
two groups based on self-reported bra cup size in order to investigate differences in
breast-related symptoms, and differences in upper body kinematics and muscle activation
during tasks of daily living.
BRSQ Scores
While there is not an exact definition of breast hypertrophy, it is widely accepted
as a characterized increase in the volume and weight of breast tissue beyond normal
proportions. Normal breast size is defined as a self-reported bra cup size of C or smaller
[1, 20].

Previous studies have concluded that women who present with breast

hypertrophy typically exhibit poorer scores on health-related quality of life instruments
[2, 14, 21, 28, 29].
Results from the analysis of the BRSQ in this study found that women in the
normal control group (defined as self-reported bra cup size of C or smaller) scored
significantly higher on the BRSQ than women in the hypertrophy group, indicating lesser
severity of breast related symptoms. These results are consistent with results from the
BRAVO study by Kerrigan et al in which it was found that only 2% of women with
normal breast sizes experience 2 or more breast related symptoms all or most of the time,
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and 87.6% of women presenting for surgical correction of breast hypertrophy list at least
two out of seven physical symptoms occurring all or most of the time [1, 20].
Static Posture
Women with breast hypertrophy generally present with numerous breast related
symptoms relating to the skeletal system including neck strain, headache, and aching
shoulders [8]. It is postulated that these symptoms are a direct result of functional
impairment caused on the musculoskeletal system due to size and position of
hypertrophic breasts.

However, examination of average static postures for the two

subject groups in this study showed no significant differences in the skeletal alignment of
the individuals in these groups.
Despite a lack of significant differences in static posture alignment found in this
study, it is important to note that the hypertrophy group did present with greater amounts
of cervical lordosis (head flexion), forward shoulder position (shoulder protraction),
thoracic kyphosis (torso flexion) and lumbar lordosis (pelvic tilt) than women in the
normal control group. These findings are supported by postulations by Letterman et al
about the structural basis for breast related symptoms related to the skeletal system in
which it is stated that the above structural changes are a direct result of a change in the
body’s center of gravity to compensate for the weight and position of hypertrophic
breasts [8].
Of increasing interest is the approaching significance of the difference in the
degree of anterior pelvic tilt during the static condition. Women in the hypertrophy
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group demonstrated values of pelvic tilt almost double the value of women in the normal
control group. Increases in anterior pelvic tilt lead to an increase in lumbar lordosis [42].
This increase in lumbar lordosis in the hypertrophy group is consistent to postulations by
Letterman et al in which it was stated that increased lumbar lordosis is a compensatory
mechanism used by women with breast hypertrophy to help keep the body in an upright
position [8].
Kinematics during Tasks of Daily Living
Changes in the body’s center of gravity may lead to secondary effects on the
functional mobility of the musculoskeletal system. However, results from this study
demonstrated few significant differences in the musculoskeletal mechanics of women
with large breasts when compared to women with normal breast sizes. Torso flexion
exhibited the most consistent differences between the two subject populations, with
normal control subjects exhibiting significantly increased torso flexion during the step up
task, as well as increased torso flexion during the pencil and sit tasks. These results are
inconsistent with findings in static posture trials where women with hypertrophic breasts
exhibited increased (although not significant) torso flexion, indicating that women with
hypertrophic breasts may compensate for baseline alterations of the spine in other ways,
such as increases in muscle activation, while performing tasks of daily living.
Muscle Activation during Tasks of Daily Living
Interestingly, these kinematic differences seen in the torso of normal control
subjects were not accompanied by significant differences in muscle activation. Despite
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having increased torso flexion during pencil, step up, and sit tasks, normal control
subjects had muscle activation values less than or similar to the muscle activation values
for the women with breast hypertrophy during the same tasks.
The pencil task was the only activity that provided a difference in muscle activity
that was approaching significance.

As mentioned before, the size and weight of

hypertrophic breasts may cause a change in the location of the body’s center of gravity.
As a subject bends down to pick up a pencil, the size and weight of the breasts may pull
the head further away from the center of gravity than it already was. As the distance from
the head to the center of gravity increases, the greater the amount of midcervical muscle
tension required to sustain the weight of the head in this position becomes [8]. In the
pencil task, women with hypertrophic breast exhibited 7.91%MVC muscle activation
compared to only 3.12%MVC muscle activation in the midcervical muscles of normal
control subjects.
While bending down to pick up a pencil, it appears that women with hypertrophic
breasts may compensate for increased midcervical activation by activating the lower
trapezius muscles in an attempt to keep the head and neck in a more upright position.
Women in the hypertrophy group exhibited 3.23%MVC muscle activation in the lower
trapezius while women in the normal control exhibited on 2.53%MVC muscle activation
during the pencil task. While this difference is only approaching significance, it may
provide important insight to the compensatory mechanisms used by the musculoskeletal
system to compensate for hypertrophic breasts.
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Posture and Muscle Activation Relationship
While the muscle activation differences between the two groups were not
significant, higher levels of muscle activation exhibited by hypertrophy subjects during
both static posture and tasks of daily living may be related to the altered static postural
alignment exhibited by these same subjects. An example of this relationship can be seen
in the lower amount of low back (erector spinae) activation in the normal control group
during static trials. Normal control group subjects exhibited less anterior pelvic tilt,
resulting in a lesser degree of lumbar lordosis. This flattening out of the lumbar lordosis
affects the thoracic spine, which extends slightly to adjust the center of gravity of the
trunk so that the energy expenditure, in terms of muscle exertion (activation), is
minimized [42].
As stated earlier in this document, posturally induced muscular weakness, or
“stretch weakness,” has been defined as the effect on muscles of remaining in a
lengthened condition, however slight, beyond the neutral (physiological rest) position
[26]. Changes in the direction of muscle pull as a result of an altered static skeletal
alignment may affect the amount of muscle tension required to maintain a static position,
thus possibly explaining chronic musculoskeletal weakness and pain experienced by
women with breast hypertrophy.
Limitations and Future Research
One major limitation of this study is the hand position in which subjects were
required to maintain throughout the data collection session. During times of data capture,
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subjects were required to place their hands on their hips throughout the duration of part or
in some cases the whole task. While this is not necessarily a natural, relaxed position, it
was necessary in order to prevent signal blockage or accidental contact to the sEMG
electrode on the serratus anterior. Therefore, it is possible that this position altered the
mechanics by which each task of daily living was performed, and may have caused a
slight deviation in the subject’s “normal” posture during static trials. However, since this
hand position was uniform across all subjects for all trials, it is unlikely that it had a
significant effect on the results of this study.
Another limitation associated with this study is the large standard deviation in
posture data between subjects. The explanation for this error can be traced to issues in
the performance of the tasks of daily living.

Subjects were given the same basic

instructions about how to perform each task. However in an effort to evaluate each
subject’s “natural” posture and mechanics used to perform each task, subjects were given
instructions to perform each task as they “normally would.” As a result there may have
been a larger amount of variance in the performance of each task than was anticipated
(i.e. bending at the waist to pick up a pencil will result in greater values of torso flexion
than squatting down to pick up a pencil).

Figures 18-21 provide a graphical

representation of the differences between a normal control subject and a hypertrophy
subject’s average head flexion, pelvic tilt, scapular protraction, and torso flexion,
respectively during the performance the pencil task.
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Figure 18. Comparison of Average Head Flexion during the Pencil Task
Average Pelvic Tilt during the Pencil Task
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Figure 19. Comparison of Average Pelvic Tilt during the Pencil Task
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Average Scapular Protraction during the Pencil Task
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Figure 20. Comparison of Average Scapular Protraction during the Pencil Task
Average Torso Flexion during the Pencil Task
40

Normal Control
Subject
Movement

35

Hypertrophy
Subject
Movement

30

Degrees

25
20
15

Normal Control Subject

10

Normal Control Static

5

Hypertrophy Subject
Hypertrophy Static

0
-5

0

50

100

150

200

Time

Figure 21. Comparison of Average Torso Flexion during the Pencil Task
This difference in movement between subjects may cause a change in the
normalized values for movement during tasks of daily living (either an increase or
decrease in value), possibly creating an outlier. While every effort was made to remove
the most extreme outliers in the data set, some mild outliers may have remained and been
included in the final analysis. Therefore, the variance in the performance of the tasks of
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daily living needs to be lowered so that the normalized data results are more consistent
between subjects and the possibility of outliers is reduced.
Another limitation of this study is large standard deviations in the muscle
activation data. This error may be traced back to the performance of MVC’s since the
resulting EMG signal is used to normalize all other tasks. The issues lie within the
subjects and whether or not they fully exerted themselves during the MVC. If a subject
did not fully exert herself during the MVC but did during one of the tasks, a value for
normalized muscle activation (%MVC) greater than 100% could result.

Therefore

variance in the performance of the MVC needs to be lowered so that the normalized data
results are more consistent between subjects.
Finally, of greatest limitation in this study is the power of each statistical test.
Statistically it is ideal for each dependent variable’s t-test to have a power of at least 0.80;
meaning β (probability of making a type II error) has a value of 0.20. However, because
the sample population in this study is so small and because the standard deviations for
each task are so high, the resulting power for each test is low. As a result, some of the
significant differences that were reported may not in fact be truly statistically significant
because the power is too low. It can be postulated that a larger sample size is needed to
detect a statistical significant difference in the dependent variables analyzed in this study
since the differences between groups were so small. Based on data from this study, each
group should have a population of at least 20 subjects in order to achieve the desirable
power and to see true statistical differences between the two groups.

76

In terms of the design of this study, it is important to remember that all subjects
were women who have never undergone nor have even been approved for breast
augmentation surgery. It was important to study women who were not actively seeking
breast reduction surgery in order to investigate trends in the musculoskeletal data for the
“normal” population. Future research should examine women who have been approved
for breast reduction surgery, and investigate differences in musculoskeletal biomechanics
pre and postoperatively. Information from future research could provide strong scientific
evidence of the medical necessity of reduction mammaplasty, thus changing criteria
insurance companies use to determine eligibility for coverage.
Conclusions
Results of this study provide scientific information regarding the effects of breast
hypertrophy on the musculoskeletal system.

Of greatest interest, are the slight

differences in both upper body posture and muscle activation seen in women with larger
breast sizes under static conditions. Under static conditions, women with larger breasts
exhibited increased head flexion, pelvic tilt, and torso flexion.

Women with larger

breasts also exhibited higher values of muscle activation in the midcervical neck muscles,
upper trapezius, lower trapezius, serratus anterior, and erector spinae during static
conditions, indicating an increase in muscle force required to maintain an upright
position. While none of the postural alterations seen in women with large breasts were
statistically significantly different from those seen in women with smaller breasts, the
data presented shows a clinical trend towards altered musculoskeletal alignment due to
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the size and weight of larger breasts. Therefore, results of this study provide scientific
evidence of the physical burdens placed on the musculoskeletal system in the case of
breast hypertrophy, and should be considered when determining the medical necessity of
reduction mammaplasty.

78

REFERENCES
1.

American Society of Plastic Surgeons, Reduction Mammaplasty: Practice
Parameters. March 9, 2002. Accessed November 16, 2008. Available at
URL address: http://www.plasticsurgery.org

2.

Blomqvist, L., A. Eriksson, and Y. Brandberg, Reduction Mammaplasty
Provides Long-Term Improvement in Health Status and Quality of Life. Plastic
and Reconstructive Surgery, 2000. 106 (5): p. 991-997.

3.

Chao, J., et al., Reduction Mammaplasty Is a Functional Operation, Improving
Quality of Life in Symptomatic Women: A Prospective, Single Center Breast
Reduction Outcome Study. Plastic and Reconstructive Surgery, 2002. 110 (7):
p. 1644-1652.

4.

Findikcioglu, K., et al., The Impact of Breast Size on the Vertebral Coumn: A
Radiologic Study. Aesthetic Plastic Surgery, 2007. 31(1): p. 23-27.

5.

Freire, M., et al., Functional Capacity and Postural Pain Outcomes after
Reduction Mammaplasty. Plastic and Reconstructive Surgery, 2007. 119 (4):
p. 1149-1155.

6.

Glatt, B., et al., A Retrospective Study of Changes in Physical Symptoms and
Body Image after Reduction Mammaplasty. Plastic and Reconstructive
Surgery, 1999. 103 (1): p. 76-82.

7.

Harbo, S., E. Jorum, and H. Roald, Reduction Mammaplasty: A Prospective
Study of Symptom Relief and Alterations of Skin. Plastic and Reconstructive
Surgery, 2003. 111 (1): p. 103-110.

8.

Letterman, G., and M. Schurter, The Effects of Mammary Hypertrophy on the
Skeletal System. Annals of Plastic Surgery, 1980. 5(6): p. 425-431.

79

9.

Netscher, D., et al., Physical and Psychosocial Symptoms among 88 Volunteer
Subjects Compared with Patients Seeking Plastic Surgery Procedures to the
Breast. Plastic and Reconstructive Surgery, 2000. 105 (7): p. 2366-2373.

10.

Krapohl, B., Functional Evaluation of the Spine in Patients with Breast
Hypertrophy. Plastic Surgical Nursing, 2005. 25 (4): p. 187-190.

11.

Cigna Healthcare, Coverage Position: Reduction Mammaplasty. August 15,
2006. Accessed February 1, 2007. Available at URL address:
http://www.cigna.com/health/provider/medical/procedural/coverage_positions/
medical/mm_0152_coveragepositioncriteria_reduction_mammaplasty_for_ma
cromastia.pdf

12.

Wagner, D., and D. Alfonso, The Influence of Obesity and Volume of Resection
on Success in Reduction Mammaplasty: An Outcomes Study. Plastic and
Reconstructive Surgery, 2005. 115 (4): p. 1034-1038.

13.

Schnur, P., et al., Reduction Mammaplasty: An Outcome Study. Plastic and
Reconstructive Surgery, 1997. 100 (4): p. 875-883.

14.

O’Blenes, C., et al., Prospective Study of Outcomes after Reduction
Mammaplasty: Long-Term Follow-Up. Plastic and Reconstructive Surgery,
2006. 117 (2): p. 351-357.

15.

Sigurdson, L., et al., Symptoms and Related Severity Experienced by Women
with Breast Hypertrophy. Plastic and Reconstructive Surgery, 2007. 119 (2):
p. 481-486.

16.

Chadbourne, E., et al., Clinical Outcomes in Reduction Mammaplasty: A
Systematic Review and Meta-analysis of Published Studies. Mayo Clinic
Proceedings, 2001. 187 (5): p. 647-650.

80

17.

Chen, T., and Wei, F., Evolution of the Vertical Reduction Mammaplasty: The
S Approach. Aesthetic Plastic Surgery, 1997. 21: p. 97-104.

18.

Hammond, D.C. Reduction Mammaplasty and Mastopexy: General
Considerations. In Spears, S.L. (Ed.), Surgery of the Breast: Principles and
Art (2nd ed.) (971-976). 1998, Philadelphia: Lippincott Williams & Wilkins.

19.

American Society of Plastic Surgeons, Cosmetic and Reconstructive Procedure
Trends. 2007. Accessed March 7, 2007. Available at URL address:
http://www.plasticsurgery.org

20.

Kerrigan, C., et al., Reduction Mammaplasty: Defining Medical Necessity.
Medical Decision Making, 2002. 22: p. 208-215.

21.

Kerrigan, C., et al., The Health Burden of Breast Hypertrophy. Plastic and
Reconstructive Surgery, 2001. 108 (6): p. 1591-1599.

22.

Harrison, A. L., Barry-Greb, T., and Wojowicz, G., Clinical Measurement of
Head and Shoulder Posture Variables. Journal of Orthopaedic and Sports
Physical Therapy, 1996. 26(6): p. 353-361.

23.

Braun, B. L., and Amundsun, L. R., Quantitative Assessment of Head and
Shoulder Posture. Archives of Physical Medicine and Rehabilitation, 1989.
70: p. 322-329.

24.

Berg, A., B. Stark, and E. Malec, Reduction Mammaplasty: a way helping
females with neck, shoulder and back pain symptoms. European Journal of
Plastic Surgery, 1994. 17: p. 84-86.

25.

Lewis, J., A. Green, and C. Wright, Subacromial Impingement Syndrome: The
Role of Posture and Muscle Imbalance. Journal of Shoulder and Elbow
Surgery, 2005. 14 (4): p. 385-392.

81

26.

Diveta, J., Walker, M.L., and Skibinski, B., Relationship Between Performance
of Selected Scapular Muscles and Scapular Abduction in Standing Subjects.
Physical Therapy, 1990. 70(8): p. 470-479.

27.

Kaye, B.L., Neurologic Changes with Excessively Large Breasts. Southern
Medical Journal, 1972. 65(2): p. 177-180.

28.

Collins, E., et al., The Effectiveness of Surgical and Nonsurgical Interventions
in Relieving the Symptoms of Macromastia. Plastic and Reconstructive
Surgery, 2002. 109 (5): p. 1556-1566.

29.

Hermans, B., et al., Quality of Life after Breast Reduction. Annals of Plastic
Surgery, 2005. 55 (3): p. 227-231.

30.

Miller, B.J., et al., Prospective Study of Outcomes after Reduction
Mammaplasty. Plastic and Reconstructive Surgery, 2005. 115(4): p. 10251031.

31.

Horizon Blue Cross Blue Shield of New Jersey, Surgery Policy for Reduction
Mammaplasty. June 24, 2004.

32.

Blue Cross of Idaho, Reduction Mammaplasty. April, 2003. Accessed April
27, 2007. Available at URL address:
http://www.bcidaho.com/providers/medical_policies/sur/mp_70121.asp.

33.

Aetna, Clinical Policy Bulletin: Breast Reduction Surgery and Gynecomastia
Surgery. March 13, 2007. Accessed April 27, 2007. Available at URL
address: http://www.aetna.com/cpb/medical/data/1_99/0017.html.

34.

Regence Group, Medical Policy: Surgery Section – Reduction Mammaplasty.
November 1, 2008. Accessed October 2, 2008. Available at URL address:
http://blue.regence.com

82

35.

Seitchick, M., Reduction Mammaplasty: Criteria for Insurance Coverage.
Plastic and Reconstructive Surgery, 1995, 95 (6): p. 1029-1032.

36.

American Society of Plastic Surgeons, Reduction Mammaplasty: ASPS
Recommended Criteria for Third Party Payers. March 9, 2002. Accessed
March 7, 2007. Available at URL address:
http://www.plasticsurgery.org/medical_professionals/Policy_Statements/Policy
-Statements.cfm

37.

Krieger, L., and M. Lesavoy, Managed Care’s Methods for Determining
Coverage of Plastic Surgery Procedures: The Example of Reduction
Mammaplasty. Plastic and Reconstructive Surgery, 2001. 107 (5): p. 12341240.

38.

Unicare, Medical Policy: Reduction Mammaplasty. November 13, 2006.
Accessed April 27, 2007. Available at URL address:
http://medpolicy.unicare.com/policies/SURG/reduction_mammaplasty.html

39.

Spector, J.A., Karp, N.S., Reduction Mammaplasty: A Significant
Improvement at Any Size. Plastic and Reconstructive Surgery, 2007. 120(4):
p. 845-850.

40.

Spector, J.A., Singh, S.P., and Karp, N.S. Out comes after Breast Reduction:
Does Size Really Matter?. Annals of Plastic Surgery, 2008. 60(5): p. 505-509.

41.

Cram, J., G. Kasman, with J. Holtz. Introduction to Surface
Electromyography. Ed. 1998, Gaithersburg, Maryland: Aspen Publishers.

42.

Nordin, M., and Frankel, V.H. Basic Biomechanics of the Musculoskeletal
System (3rd Ed.). Ed. 2001, Philadelphia: Lippincott Williams & Wilkins.

83

APPENDIX A
Breast Related Symptoms Questionnaire

84

Copy of the questionnaire each subject completed prior to data collection [21].
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APPENDIX B
Pictures of Surface Electrode Placement
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Figure B 1. Midcervical (C-4) Paraspinal Electrode Placement

Figure B 2. Upper Trapezius Surface Electrode Placement

Figure B 3. Lower Trapezius Surface Electrode Placement
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Figure B 4. Serratus Anterior Surface Electrode Placement

Figure B 5. Erector Spinae Surface Electrode Placement
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APPENDIX C
Pictures of Complete Subject Setup
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Figure C 1. Complete Subject Setup (Posterior View)

Figure C 2. Complete Subject Setup (Side View)

